<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>行舟Drug | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-06T01:08:44+08:00</updated>
  <subtitle>It takes nothing to join the crowd, but it takes everything to stand alone</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>CDE专业解读-ICH M4 CTD PPT以及问答</title>
    <updated>2020-12-05T20:59:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/hQYx6T3Z7zCZk8CimV-N7g</id>
    <link href="https://mp.weixin.qq.com/s/hQYx6T3Z7zCZk8CimV-N7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新药物风险投资策略现状研究</title>
    <updated>2020-12-05T20:59:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/0FuMq9YB9TIKfPexnCvvUQ</id>
    <link href="https://mp.weixin.qq.com/s/0FuMq9YB9TIKfPexnCvvUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中英文 ICH-Q8,Q9,Q10 课件ppt</title>
    <updated>2020-12-05T20:59:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/cA9bzEVIx3OFcIJt9c4cNw</id>
    <link href="https://mp.weixin.qq.com/s/cA9bzEVIx3OFcIJt9c4cNw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一图读懂：癌症患者如何选择靶向药？</title>
    <updated>2020-12-04T20:08:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/Za69pBBOBf_Vi-IqVq0GJA</id>
    <link href="https://mp.weixin.qq.com/s/Za69pBBOBf_Vi-IqVq0GJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>行业研究｜遗传病基因检测行业研究报告</title>
    <updated>2020-12-04T20:08:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/5A_oAKe9rg3_JVPN466H4w</id>
    <link href="https://mp.weixin.qq.com/s/5A_oAKe9rg3_JVPN466H4w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗肿瘤新药单臂研究临床原则来了！</title>
    <updated>2020-12-04T20:08:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/9st4E2e-4W-2_7actnLkSw</id>
    <link href="https://mp.weixin.qq.com/s/9st4E2e-4W-2_7actnLkSw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ICH指导原则培训答疑实录20201127日</title>
    <updated>2020-12-03T21:40:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/Qgrbmsu1oSQ67XKyxg_ZWw</id>
    <link href="https://mp.weixin.qq.com/s/Qgrbmsu1oSQ67XKyxg_ZWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NMPA综合司公开征求《药物警戒质量管理规范（征求意见稿）》意见</title>
    <updated>2020-12-03T21:40:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/xElvWbsO32xouV8G997lLQ</id>
    <link href="https://mp.weixin.qq.com/s/xElvWbsO32xouV8G997lLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>12月1日起，这15条问题，CDE发补！仿制药或只发补1次，请珍惜机会！</title>
    <updated>2020-12-03T21:40:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/MIUJWfRmV_zdkAfliS3fJQ</id>
    <link href="https://mp.weixin.qq.com/s/MIUJWfRmV_zdkAfliS3fJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>低溶解性药物平衡溶解度测定的影响因素研究</title>
    <updated>2020-12-02T20:51:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/be7yQap5XsobI2dGb1lsGQ</id>
    <link href="https://mp.weixin.qq.com/s/be7yQap5XsobI2dGb1lsGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>自今日起，药品审评只发补一次</title>
    <updated>2020-12-02T20:51:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/X7Praur5ye4TEjVz426iCQ</id>
    <link href="https://mp.weixin.qq.com/s/X7Praur5ye4TEjVz426iCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【干货】基于原料药性质的口服固体制剂生产工艺路线选择</title>
    <updated>2020-12-02T20:51:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/U9ttCWo25MIic7T0SVq66A</id>
    <link href="https://mp.weixin.qq.com/s/U9ttCWo25MIic7T0SVq66A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【干货】最新ICH-Q1、Q9、Q10、Q3D、Q6A、E4、M4指导原则培训视频免费看</title>
    <updated>2020-12-01T21:02:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/e0ZLDvBcfkd_0vThJzcbkw</id>
    <link href="https://mp.weixin.qq.com/s/e0ZLDvBcfkd_0vThJzcbkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>我国仿制药质量关键影响因素分析</title>
    <updated>2020-12-01T21:02:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/MfgALe-WDk_TF2X2gYirtA</id>
    <link href="https://mp.weixin.qq.com/s/MfgALe-WDk_TF2X2gYirtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR-T细胞疗法最新研究进展</title>
    <updated>2020-12-01T21:02:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/kcO0CHnYCgWWZQtXW3mm9A</id>
    <link href="https://mp.weixin.qq.com/s/kcO0CHnYCgWWZQtXW3mm9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布晚期肝细胞癌临床试验终点技术指导原则！</title>
    <updated>2020-11-30T19:01:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/rgwPhd-pFVEEl4GKwZNWwg</id>
    <link href="https://mp.weixin.qq.com/s/rgwPhd-pFVEEl4GKwZNWwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>官方解读：真实世界数据不能取代现有临床评价路径</title>
    <updated>2020-11-30T19:01:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/lTgA0AuABMqT17SvlrprQA</id>
    <link href="https://mp.weixin.qq.com/s/lTgA0AuABMqT17SvlrprQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【收藏】IND、NDA的溶出方法开发确认</title>
    <updated>2020-11-30T19:01:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/W6WXate1kFQX8qFCax3HrA</id>
    <link href="https://mp.weixin.qq.com/s/W6WXate1kFQX8qFCax3HrA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【课件分享】原料药变更管理与发补回复策略浅析</title>
    <updated>2020-11-30T19:01:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/3lie8N0ogAXifORkTCyOXA</id>
    <link href="https://mp.weixin.qq.com/s/3lie8N0ogAXifORkTCyOXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>严重副作用不同疾病的对应手册（面向患者·公众）（47）-血小板减少症</title>
    <updated>2020-11-29T19:26:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/UcIRb2Lnb7n06zlzS5Rerg</id>
    <link href="https://mp.weixin.qq.com/s/UcIRb2Lnb7n06zlzS5Rerg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>